Europe Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.
No. of Pages: 136 | Report Code: BMIRE00032024 | Category: Life Sciences
No. of Pages: 136 | Report Code: BMIRE00032024 | Category: Life Sciences
The Europe organoids services market size is expected to reach US$ 5,016.03 million by 2031 from US$ 1,233.51 million in 2024. The market is estimated to record a CAGR of 22.2% from 2024 to 2031.
The Europe organoid services market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. The regional market growth is associated with the rising demand for tissue engineering and organ transplantation; increasing adoption of organoids in disease modeling, gene mutation, and tumor modeling; and an upsurge in R&D on organoids. In addition, increased funding and public–private investments would create significant opportunities in the market in the coming years.
Key segments that contributed to the derivation of the Europe organoids services market analysis are type, application, and source.
The growing demand for personalized medicine in Europe is significantly shaping the development and use of organoid technologies, especially in oncology and genetic disorders. A notable example of this innovation is the collaboration between King's College London and GSK, where researchers are creating patient-derived lung cancer organoids to predict relapse and identify effective treatment combinations. These organoids reflect the unique genetic mutations present in each patient's cancer, enabling tailored therapy selection. Moreover, the European Medicines Agency (EMA) has acknowledged the significance of organoid technology in precision medicine. The EMA's adaptive pathways initiative supports the use of innovative methods like organoids to expedite the approval process for new therapies, thereby facilitating the transition from research to clinical application.
Based on country, the Europe organoids services market comprises the UK, France, Germany, Spain, Italy, and the Rest of Europe. Germany held the largest share in 2024.
The demand for organoids services in Germany is growing significantly with the rising tissue engineering and organ transplantation activities and progressing organoid research. With the flourishing research sector, new sources of organoid generation are emerging that advance the role of organoids in human disease modeling, thereby opening new avenues. The biotechnology industry in Germany exhibits enormous growth potential due to the high quality of its finished products. Moreover, many companies offering services related to organoids are operational in the country. For instance, Max Delbrück Center , based in Berlin, offers platform services for organoid derivation and their further characterization.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 1,233.51 Million |
| Market Size by 2031 | US$ 5,016.03 Million |
| Global CAGR (2024 - 2031) | 22.2% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
Some of the key players operating in the market include CUSABIO TECHNOLOGY LLC; Cyprio; Eurofins Scientific SE; HUB Organoids B.V. (Hubrecht Organoid Technology); InnoSer; InSphero; LABTOO; Molecular Devices, LLC.; Oncodesign Services; and Sino Biological Inc., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
The Europe Organoids Services Market is valued at US$ 1,233.51 Million in 2024, it is projected to reach US$ 5,016.03 Million by 2031.
As per our report Europe Organoids Services Market, the market size is valued at US$ 1,233.51 Million in 2024, projecting it to reach US$ 5,016.03 Million by 2031. This translates to a CAGR of approximately 22.2% during the forecast period.
The Europe Organoids Services Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Organoids Services Market report:
The Europe Organoids Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Organoids Services Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Organoids Services Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Organoids Services Market
